IS RESEEDING FROM THE PRIMARY A PLAUSIBLE CAUSE OF NODE FAILURE

被引:8
作者
DUBRAY, BM
BATAINI, JP
BERNIER, J
THAMES, HD
LAVE, C
ASSELAIN, B
JAULERRY, C
BRUNIN, F
PONTVERT, D
机构
[1] INST CURIE, DEPT RADIOTHERAPY, F-75231 PARIS 05, FRANCE
[2] INST CURIE, DEPT STAT, F-75231 PARIS 05, FRANCE
[3] MD ANDERSON CANC CTR, DEPT BIOMATH, HOUSTON, TX 77033 USA
[4] OSPED SAN GIOVANNI BELLINZONA, DEPT RADIOTHERAPY, CH-6504 BELLINZONA, SWITZERLAND
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1993年 / 25卷 / 01期
关键词
CERVICAL NODES; HEAD AND NECK CARCINOMAS; RADIOTHERAPY; RESEEDING TO THE NODES; PATIENTS EXCLUSION; DOSE-TIME-CONTROL RELATIONSHIPS;
D O I
10.1016/0360-3016(93)90138-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a previous analysis of node failures in 1251 consecutive patients with node positive oropharyngeal and pharyngo-laryngeal squamous cell carcinomas treated by external radiotherapy alone at the Institut Curie, the main reasons for patient exclusion were node recurrence associated with primary failure (N + T failures) and doses less than 55 Gy. These exclusions reduced the number of node failures from 399/1251 (32%) to 77/798 (10%). Multivariate analysis of node recurrence indicated that node size and fixity, treatment duration, and T stage of primary were significant (higher probability of isolated node failure for the T1-T2 primaries). In the present analysis, it is noted that 60% of the N + T failures were observed less than 1 month after the completion of the irradiation and, therefore, were not likely the result of reseeding from the primary tumor. When all 1251 patients were included in the analysis, the probability of nodal failure increased for larger nodes, T4 primaries, lower nodal doses, presence of contralateral node metastases, and nodal fixation to the surrounding structures. No influence of the primary site was found. Treatment duration was closely associated with total dose to the nodes. The best description of the data was obtained with a model including total dose and not treatment time. However, as in the previous analysis, the exclusion of low-dose (less than 55 Gy) treatments resulted in the loss of a significant dose-control relationship. We conclude that the majority of node failures is unlikely to result from reseeding from the primary tumor, and therefore should not be excluded from local-control analyses. From a more radiobiological point of view, the exclusion of palliative treatments is questionable when studying the effect of dose on local control.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 30 条
[1]   RADIOTHERAPY OF LYMPH-NODE METASTASES IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK REGION [J].
BARTELINK, H ;
BREUR, K ;
HART, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (06) :983-989
[2]   PRIMARY RADIOTHERAPY OF SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX AND PHARYNGOLARYNX - TENTATIVE MULTIVARIATE MODELING SYSTEM TO PREDICT THE RADIOCURABILITY OF NECK NODES [J].
BATAINI, JP ;
BERNIER, J ;
ASSELAIN, B ;
LAVE, C ;
JAULERRY, C ;
BRUNIN, F ;
PONTVERT, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (04) :635-642
[3]  
BATAINI JP, 1990, LARYNGOSCOPE, V100, P716
[4]   NATURAL-HISTORY OF NECK DISEASE IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF OROPHARYNX AND PHARYNGOLARYNX [J].
BATAINI, JP ;
BERNIER, J ;
BRUGERE, J ;
JAULERRY, C ;
PICCO, C ;
BRUNIN, F .
RADIOTHERAPY AND ONCOLOGY, 1985, 3 (03) :245-255
[5]  
BATAINI JP, 1982, ADENOPATHIES CERVICA
[6]   CLINICAL RADIOBIOLOGY OF MALIGNANT-MELANOMA [J].
BENTZEN, SM ;
OVERGAARD, J ;
THAMES, HD ;
OVERGAARD, M ;
HANSEN, PV ;
VONDERMAASE, H ;
MEDER, J .
RADIOTHERAPY AND ONCOLOGY, 1989, 16 (03) :169-182
[7]   REGIONAL OUTCOME IN OROPHARYNGEAL AND PHARYNGOLARYNGEAL CANCER TREATED WITH HIGH-DOSE PER FRACTION RADIOTHERAPY - ANALYSIS OF NECK DISEASE RESPONSE IN 1646 CASES [J].
BERNIER, J ;
BATAINI, JP .
RADIOTHERAPY AND ONCOLOGY, 1986, 6 (02) :87-103
[8]  
BRUGERE J, 1980, M SOC FRANCAISE CARC
[9]   AN APPROACH TO THE INTERPRETATION OF CLINICAL-DATA ON THE TUMOR-CONTROL PROBABILITY-DOSE RELATIONSHIP [J].
DUTREIX, J ;
TUBIANA, M ;
DUTREIX, A .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (03) :239-248
[10]  
Fletcher G, 1980, TXB RADIOTHERAPY